ly3437943 retatrutide triple agonist glp-1 gip glucagon (LY3437943): Mechanism of Action and Research Overview Retatrutide Triple Agonist Research Peptide

A study conducted on rat model demonstrated that liraglutide effectively reduced the mean arterial pressure, a cardinal feature for preeclampsia, leading to decreased blood urea nitrogen (BUN) and creatinine via renal vasodilation

STEP series clinical trials of Semaglutide Novo's two obesity products, Wegovy and Saxenda, have generated DKK 16.86bn (USD 2.5bn) in sales throughout 2022, doubling the preceding year's result of DKK 8.4bn (USD 1.2bn) an increase of 101%

Looking Ahead The future of GLP-1 receptor agonists is incredibly promising

Long-acting dosage forms have more advantages in blood sugar control due to their longer half-life and stable blood concentration

Table 2 Clinical studies elucidating the use of antidiabetics against glaucoma